Evaluation of pharmacodynamic (PD) biomarkers in patients with metastatic pancreatic cancer treated with BL-8040, a novel CXCR4 antagonist.Manuel Hidalgo, Daniel D. Von Hoff, Talia Golan et al.|Journal of Clinical Oncology|2018Cited by 6
Evaluation of pharmacodynamic (PD) biomarkers in patients with metastatic pancreatic cancer treated with BL-8040, a novel CXCR4 antagonist.Manuel Hidalgo, Daniel D. Von Hoff, Ron Epelbaum et al.|Journal of Clinical Oncology|2018Cited by 0